Business context and reporting period
The supplied filing is Tempur-Pedic International Inc.’s Form 10-K for the fiscal year ended December 31, 2011; it does not identify Somnigroup International Inc. as the registrant. The filing covers a manufacturer and marketer of premium mattresses, pillows and related products sold in approximately 80 countries, through North America and International segments.
Full-year results are presented below, with fourth-quarter 2011 results included separately. Unless noted, amounts are in U.S. dollars.
Financial performance
| Metric | FY 2011 | FY 2010 | Change |
|---|---|---|---|
| Net sales | $1,417.9 million | $1,105.4 million | +28.3% |
| Gross profit / margin | $743.1 million / 52.4% | $555.4 million / 50.2% | Margin +2.2 percentage points |
| Operating income / margin | $340.5 million / 24.0% | $245.9 million / 22.2% | Margin +1.8 percentage points |
| Net income / margin | $219.6 million / 15.5% | $157.1 million / 14.2% | Net income +39.8% |
| Diluted EPS | $3.18 | $2.16 | Up from prior year |
| Cash from operations | $248.7 million | $184.1 million | +$64.6 million |
| Capital expenditures | $29.5 million | $18.1 million | +$11.3 million |
- Fourth quarter: Net sales were $366.8 million, gross profit $191.2 million, operating income $85.8 million and net income $56.3 million. The comparable 2010 figures were $292.7 million, $151.8 million, $71.6 million and $46.3 million, respectively.
- Sales mix: Retail generated 87.8% of 2011 sales; Direct 7.1%, Healthcare 2.4% and third-party distributors 2.7%. Mattresses accounted for 66.6% of sales, pillows 10.7% and other products 22.7%.
- Segments: North American sales rose 30.1% to $1,004.7 million; International sales rose 23.9% to $413.2 million, or approximately 15.7% on a constant-currency basis. North America gross margin improved to 49.7% from 46.4%; International gross margin slipped to 58.9% from 59.1%.
- Liquidity and debt: Cash and cash equivalents were $111.4 million, working capital $196.3 million and long-term debt $585.0 million at year-end. Debt was $407.0 million a year earlier. Revolver availability was approximately $184.0 million after borrowings and letters of credit. Funded debt to EBITDA was 1.50x versus a 3.0x covenant maximum; the company reported covenant compliance.
- Capital returns: The company repurchased 6.5 million shares for $368.5 million during 2011. Stockholders’ equity declined to $30.8 million from $126.0 million. No dividends were paid in 2011 or 2010.
Material changes versus the prior comparable period
- Sales growth was driven principally by retail-channel expansion, marketing investment and new products, including the TEMPUR-Cloud and TEMPUR-Contour collections. North American retail sales increased 32.1%.
- Gross margin improved overall, aided in North America by manufacturing and distribution productivity, favorable mix and volume leverage. Higher raw-material costs partly offset those gains. International margin also faced freight costs and temporary productivity issues during a manufacturing IT upgrade.
- Selling and marketing expense increased 38.6% to $276.9 million; advertising expense rose 54.0% to $148.8 million. General and administrative expense rose 14.5% to $125.7 million, though it declined as a proportion of sales.
- Operating cash flow increased alongside earnings. Receivables and inventory also grew to support sales. Financing included substantial share repurchases, partly funded by increased borrowings.
Outlook, risks and unusual items
- Management expected 2012 gross margin to increase for the full year, supported by productivity programs and volume leverage, partly offset by higher commodity costs. The filing gives no specific 2012 revenue or EPS guidance.
- Management expected approximately $50 million of 2012 capital expenditures, including IT investments and a new Lexington headquarters. Expected 2012 cash interest payments were approximately $19 million. Management stated that operating cash flow and facility availability were expected to meet anticipated needs, while cautioning that this was not assured.
- The 2012 outlook assumed modestly unfavorable currency movements versus 2011. A 100-basis-point increase in rates on unhedged variable-rate debt was estimated to reduce annual pretax income by about $3.4 million. A swap fixed the LIBOR-based rate at 1.25% on $250 million of borrowings, subject to a declining balance, through December 2015.
- On January 23, 2012, the board authorized up to $250 million in additional repurchases, which could be funded with operating cash or borrowings.
- Tax contingency: Danish tax assessments concerning intercompany royalties totaled approximately $103.1 million, including interest and penalties. The matter was disputed and on hold pending a bilateral pricing agreement process. The filing also disclosed $16.1 million of accrued unrecognized tax benefits, including interest and penalties, whose payment timing could not be estimated.
- Litigation: The company disclosed a pending antitrust class action and an appeal by the New York Attorney General concerning the company’s retail pricing policy. Management considered losses remote, but stated that outcomes could not be predicted.
- Other key risks include macroeconomic weakness and discretionary-spending pressure, competition and customer concentration (top five customers represented about 20% of sales), raw-material inflation, foreign exchange, product returns and warranty estimates, supplier or manufacturing disruption, and leverage. North American returns were $46.7 million, or 4.6% of segment sales, versus 5.8% in 2010.
- Ernst & Young issued unqualified opinions on the financial statements and internal control over financial reporting. Management reported effective disclosure controls and internal controls.
Important facts for investors to verify
- Confirm the intended issuer: this filing is for Tempur-Pedic International Inc., not the company named in the request metadata.
- Review the full financial statements and debt agreement for maturity, borrowing availability, covenant definitions and the effect of further repurchases on leverage and equity.
- Track the Danish tax assessment and the bilateral pricing agreement process, including potential exposure beyond the assessed years.
- Monitor 2012 gross-margin assumptions against commodity inflation, currency movements, retail demand and the costs or benefits of the manufacturing IT upgrade.
- Check developments in the antitrust matters, customer concentration, returns and warranty reserves, and the execution and financing of the new repurchase authorization.